IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - ELI:IBS - PTIBS0AM0008 - Common Stock
10.1 EUR
+0.1 (+1%)
IBS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 53 industry peers in the Hotels, Restaurants & Leisure industry. IBS has an average financial health and profitability rating. IBS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
IBS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years IBS had a positive operating cash flow.
1.2 Ratios
IBS has a Return On Assets of 1.16%. This is comparable to the rest of the industry: IBS outperforms 47.17% of its industry peers.
IBS has a Return On Equity of 2.54%. This is comparable to the rest of the industry: IBS outperforms 54.72% of its industry peers.
IBS's Return On Invested Capital of 3.13% is in line compared to the rest of the industry. IBS outperforms 43.40% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBS is significantly below the industry average of 10.61%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROIC | 3.13% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
IBS has a Profit Margin of 1.74%. This is comparable to the rest of the industry: IBS outperforms 47.17% of its industry peers.
In the last couple of years the Profit Margin of IBS has declined.
With a Operating Margin value of 4.61%, IBS perfoms like the industry average, outperforming 47.17% of the companies in the same industry.
In the last couple of years the Operating Margin of IBS has declined.
The Gross Margin of IBS (49.59%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of IBS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBS is destroying value.
Compared to 1 year ago, IBS has less shares outstanding
The number of shares outstanding for IBS has been increased compared to 5 years ago.
IBS has a worse debt/assets ratio than last year.
2.2 Solvency
IBS has an Altman-Z score of 1.98. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
IBS's Altman-Z score of 1.98 is fine compared to the rest of the industry. IBS outperforms 60.38% of its industry peers.
IBS has a debt to FCF ratio of 6.53. This is a slightly negative value and a sign of low solvency as IBS would need 6.53 years to pay back of all of its debts.
IBS has a better Debt to FCF ratio (6.53) than 60.38% of its industry peers.
IBS has a Debt/Equity ratio of 0.69. This is a neutral value indicating IBS is somewhat dependend on debt financing.
IBS has a Debt to Equity ratio of 0.69. This is in the better half of the industry: IBS outperforms 69.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Altman-Z | 1.98 |
ROIC/WACC0.5
WACC6.2%
2.3 Liquidity
IBS has a Current Ratio of 1.09. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.09, IBS is doing good in the industry, outperforming 62.26% of the companies in the same industry.
IBS has a Quick Ratio of 1.01. This is a normal value and indicates that IBS is financially healthy and should not expect problems in meeting its short term obligations.
IBS has a Quick ratio (1.01) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
IBS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.78%.
IBS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, IBS shows a quite strong growth in Revenue. The Revenue has grown by 15.22% in the last year.
Measured over the past years, IBS shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
3.2 Future
The Earnings Per Share is expected to grow by 18.23% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.79% on average over the next years.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.23%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.79%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IBS is valuated quite expensively with a Price/Earnings ratio of 50.50.
IBS's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.20. IBS is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 23.67 indicates a rather expensive valuation of IBS.
IBS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, IBS is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.5 | ||
| Fwd PE | 23.67 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued cheaply inside the industry as 81.13% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.76 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IBS's earnings are expected to grow with 20.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
IBS has a Yearly Dividend Yield of 7.10%, which is a nice return.
Compared to an average industry Dividend Yield of 3.03, IBS pays a better dividend. On top of this IBS pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.1% |
5.2 History
On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
242.99% of the earnings are spent on dividend by IBS. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP242.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (9/16/2025, 7:00:00 PM)
10.1
+0.1 (+1%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners24.17%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap419.25M
Analysts83.33
Price Target11.82 (17.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.1% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP242.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)11.84%
Min Revenue beat(2)11.28%
Max Revenue beat(2)12.41%
Revenue beat(4)4
Avg Revenue beat(4)8.54%
Min Revenue beat(4)0.18%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)-36.9%
EPS NY rev (3m)-36.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 50.5 | ||
| Fwd PE | 23.67 | ||
| P/S | 0.85 | ||
| P/FCF | 8.76 | ||
| P/OCF | 5.32 | ||
| P/B | 1.24 | ||
| P/tB | 1.76 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.2
EY1.98%
EPS(NY)0.43
Fwd EY4.23%
FCF(TTM)1.15
FCFY11.41%
OCF(TTM)1.9
OCFY18.81%
SpS11.85
BVpS8.12
TBVpS5.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.16% | ||
| ROE | 2.54% | ||
| ROCE | 4.01% | ||
| ROIC | 3.13% | ||
| ROICexc | 4.09% | ||
| ROICexgc | 5.28% | ||
| OM | 4.61% | ||
| PM (TTM) | 1.74% | ||
| GM | 49.59% | ||
| FCFM | 9.73% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 6.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 6.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 560.26% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.98 |
F-Score6
WACC6.2%
ROIC/WACC0.5
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.78%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%-314.5%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.23%
Revenue 1Y (TTM)15.22%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%17.83%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.79%
EBIT growth 1Y0.48%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year399.89%
EBIT Next 3Y91.9%
EBIT Next 5Y57.35%
FCF growth 1Y-27.17%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y-26.24%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%